5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain

      review-article
      1 , 1 , *
      Biophysical Chemistry
      Elsevier B.V.
      SARS CoV E protein, Membrane, Structure, Covid-19, Amyloidogenesis, CoV, Coronavirus, SARS, Severe Acute Respiratory Syndrome, CoV-2, Coronavirus-2, MERS-CoV, Middle East respiratory syndrome Coronavirus, ORFs, open reading frames, S, spike, E, envelope, M, membrane protein, N, nucleocapsid, ACE2, angiotensin-converting enzyme 2, RNA, Ribonucleic Acid, ER, Endoplasmic Reticulum, ERGIC, Endoplasmic Reticulum-Golgi intermediate compartment, TMD, transmembrane domain, SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, Asp, Aspartate, PBD, PDZ-binding domain, IBV, Infectious bronchitis virus, MHV, Mouse hepatitis virus, NMR, Nuclear Magnetic Resonance, mRNA, Messenger RNA, Cys, Cystein, cDNA, complementary Deoxyribonucleic Acid, LLPS, liquid-liquid phase separation, IDRs, intrinsically disordered regions, LCDs, low complexity domains, BLAST, basic local alignment search tool, MEGA, Molecular Evolutionary Genetics Analysis, Pro, Proline, HMA, 5-(N, N-hexamethylene)amiloride, Val, Valine, Leu, Leucine;, Bcl-xL, B-cell lymphoma-extra-large.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Envelope (E) protein in SARS Coronavirus (CoV) is a small structural protein, incorporated as part of the envelope. A major fraction of the protein has been known to be associated with the host membranes, particularly organelles related to intracellular trafficking, prompting CoV packaging and propagation. Studies have elucidated the central hydrophobic transmembrane domain of the E protein being responsible for much of the viroporin activity in favor of the virus. However, newer insights into the organizational principles at the membranous compartments within the host cells suggest further complexity of the system. The lesser hydrophobic Carboxylic-terminal of the protein harbors interesting amino acid sequences- suggesting at the prevalence of membrane-directed amyloidogenic properties that remains mostly elusive. These highly conserved segments indicate at several potential membrane-associated functional roles that can redefine our comprehensive understanding of the protein. This should prompt further studies in designing and characterizing of effective targeted therapeutic measures.

          Graphical abstract

          Highlights

          • The SARS CoV Envelope protein is a small structural protein of the virus that has been suggested to have significant viroporin like activity.

          • Majority of its function is mediated at the interface of host-membrane interactions.

          • Focus at the membrane-directed features of the protein provide useful insight into gaining mechanistic insight into its viroporin functions.

          • Studies have elaborated the central hydrophobic transmembrane domain of E protein, known to affect ion-channel formation.

          • The C-terminal region of the protein show further potential host-membrane directed functional roles.

          • The highly conserved amyloidogenic amino acid stretches of the C-terminal suggest at significant contribution to CoV propagation.

          • Comprehensive understanding of the roles of each segment of the protein can help in defining newer therapeutic target sequences.

          Related collections

          Most cited references91

          • Record: found
          • Abstract: found
          • Article: not found

          Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

          Summary Background In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed. Methods We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus. Findings The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99·98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues. Interpretation 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensin-converting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation. Funding National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Shandong First Medical University.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

            A previously unknown coronavirus was isolated from the sputum of a 60-year-old man who presented with acute pneumonia and subsequent renal failure with a fatal outcome in Saudi Arabia. The virus (called HCoV-EMC) replicated readily in cell culture, producing cytopathic effects of rounding, detachment, and syncytium formation. The virus represents a novel betacoronavirus species. The closest known relatives are bat coronaviruses HKU4 and HKU5. Here, the clinical data, virus isolation, and molecular identification are presented. The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

              An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.
                Bookmark

                Author and article information

                Contributors
                Journal
                Biophys Chem
                Biophys. Chem
                Biophysical Chemistry
                Elsevier B.V.
                0301-4622
                1873-4200
                11 August 2020
                11 August 2020
                : 106452
                Affiliations
                Department of Biophysics, Bose Institute, P-1/12 CIT Scheme VII(M), Kolkata 700054, India
                Author notes
                [* ]Corresponding author. anirbanbhunia@ 123456gmail.com
                [1]

                Both authors contributed equally.

                Article
                S0301-4622(20)30160-5 106452
                10.1016/j.bpc.2020.106452
                7418743
                32818817
                be82a11b-b857-412b-9037-c06dafdccbf2
                © 2020 Elsevier B.V. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 10 July 2020
                : 1 August 2020
                : 1 August 2020
                Categories
                Article

                Biochemistry
                sars cov e protein,membrane,structure,covid-19,amyloidogenesis,cov, coronavirus,sars, severe acute respiratory syndrome,cov-2, coronavirus-2,mers-cov, middle east respiratory syndrome coronavirus,orfs, open reading frames,s, spike,e, envelope,m, membrane protein,n, nucleocapsid,ace2, angiotensin-converting enzyme 2,rna, ribonucleic acid,er, endoplasmic reticulum,ergic, endoplasmic reticulum-golgi intermediate compartment,tmd, transmembrane domain,sds-page, sodium dodecyl sulfate–polyacrylamide gel electrophoresis,asp, aspartate,pbd, pdz-binding domain,ibv, infectious bronchitis virus,mhv, mouse hepatitis virus,nmr, nuclear magnetic resonance,mrna, messenger rna,cys, cystein,cdna, complementary deoxyribonucleic acid,llps, liquid-liquid phase separation,idrs, intrinsically disordered regions,lcds, low complexity domains,blast, basic local alignment search tool,mega, molecular evolutionary genetics analysis,pro, proline,hma, 5-(n, n-hexamethylene)amiloride,val, valine,leu, leucine;,bcl-xl, b-cell lymphoma-extra-large.

                Comments

                Comment on this article